Jeffrey A Munsie is Chief Legal Officer of CONCERT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of CNCE, which is worth approximately $0. The most recent transaction as insider was on Mar 06, 2023, when has been sold 49,699 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jeffrey A Munsie Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2023
SELL
Sale (or disposition) back to the issuer
-
49,699 Reduced 100.0%
0 Common Stock
Mar 06 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
38,350 Reduced 100.0%
0 Common Stock
Feb 15 2023
SELL
Open market or private sale
$31,375 $8.34 p/Share
3,762 Reduced 4.1%
88,049 Common Stock
Jan 30 2023
SELL
Open market or private sale
$70,916 $8.35 p/Share
8,493 Reduced 8.47%
91,811 Common Stock
Jan 06 2023
SELL
Open market or private sale
$20,974 $7.25 p/Share
2,893 Reduced 2.8%
100,304 Common Stock
Feb 14 2022
SELL
Open market or private sale
$11,625 $3.09 p/Share
3,762 Reduced 3.52%
103,197 Common Stock
Jan 28 2022
BUY
Grant, award, or other acquisition
-
63,700 Added 37.33%
106,959 Common Stock
Jan 05 2022
SELL
Open market or private sale
$9,261 $3.2 p/Share
2,894 Reduced 6.27%
43,259 Common Stock
Feb 16 2021
SELL
Open market or private sale
$27,545 $7.32 p/Share
3,763 Reduced 7.54%
46,153 Common Stock
Jan 05 2021
BUY
Grant, award, or other acquisition
-
21,700 Added 30.3%
49,916 Common Stock
JAM

Jeffrey A Munsie

Chief Legal Officer
Lexington, MA

Track Institutional and Insider Activities on CNCE

Follow CONCERT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNCE shares.

Notify only if

Insider Trading

Get notified when an Concert Pharmaceuticals, Inc. insider buys or sells CNCE shares.

Notify only if

News

Receive news related to CONCERT PHARMACEUTICALS, INC.

Track Activities on CNCE